ISHLT Re-Elects Daniel F. Dilling to Board of Directors

6 January, 2021 – Daniel F. Dilling, MD, Medical Director of Lung Transplantation at Loyola University Medical Center in Maywood, IL USA, has been re-elected as a Director on the Board of the International Society for Heart and Lung Transplantation.

“To be a part of the Board of Directors of the ISHLT during this trying time is both humbling and daunting, but I look forward to the challenges,” Dr. Dilling said. “A vigorous ISHLT is essential to our day-to-day work as a vehicle of learning for our transplant teams and ultimately enhancing the health and well-being of our patients.”

ISHLT is committed to improving the care of patients with advanced heart and lung disease through research, education, and advocacy, and is the world’s largest multi-disciplinary organization of its kind. ISHLT will welcome Dr. Dilling as Director at the 41st Annual ISHLT Annual Meeting & Scientific Sessions in April 2021.

Dr. Dilling is a dedicated clinician and researcher, leading the lung transplant team at Loyola University Chicago, Stritch School of Medicine. His research includes analysis of outcomes of recipients of lung transplants as well as new therapies directed at rare lung diseases like pulmonary fibrosis and lymphangioleiomyomatosis (LAM).

Dr. Dilling has served as Academy Chair for the Lung Transplantation Master Class, Co-Director for the Lung Transplantation Academy Core Competency Class, Education Workforce leader on the Pulmonary Council, on the Strategic Planning Committee, as Chair of the Junior Faculty and Trainee Council, on multiple Annual Meeting Program Committees, and a speaker at various Annual ISHLT Meetings.


The International Society for Heart and Lung Transplantation is a not-for-profit, multidisciplinary professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies. With more than 3,800 members in more than 45 countries, ISHLT is the world’s largest organization dedicated to the research, education and advocacy of end-stage heart and lung disease. ISHLT members represent more than 15 different professional disciplines. For more information, visit